Jason Soffe – Global research collaboration for infectious disease preparednessGLOPID-R

Pasteur Network

France

Represented by Rebecca Grais

Bill & Melinda Gates Foundation

USA

Represented by David W. Vaughn

Japan Agency for Medical Research and Development (AMED)

Japan

Represented by Shoji Miyagawa

National Institute of Health Carlos III (ISCIII)

Spain

Represented by Tomás López-Peña

National Council of Science and Technology (CONACYT)

Mexico

Represented by Juan José Serrato

Indian Council of Medical Research (ICMR)

India

Represented by Samiran Panda

International Development Research Centre (IDRC)

Canada

Represented by John Dusabe-Richards

Medical Research Council (MRC)

United Kingdom

Represented by Anna Kinsey

European Commission

Represented by Barbara Kerstiens (DG Research and Innovation)

UK Department of Health & Social Care

United Kingdom

Represented by Lucy Chappell

Sao Paulo Research Foundation (FAPESP)

Brazil

Represented by Reinaldo Salomao

Academy of Scientific Research & Technology (ASRT)

Egypt

Represented by Amr Radwan

South African Medical Research Council (SAMRC)

South Africa

Represented by Charles Shey Wiysonge

National Council for Science and Technology (NCST)

Rwanda

Represented by Eugene Mutimura

National Research Foundation of Korea

Korea

Represented by Choong-Min Ryu

Netherlands Organisation for Health research and Development (ZonMw)

Netherlands

Represented by Suzanne Verver

Swiss National Science Foundation (SNSF)

Switzerland

Represented by Matthias Egger

Coalition for Epidemic Preparedness Innovations (CEPI)

Observer

Represented by Richard Hatchett & Frederik Kristensen

National Research and Innovation Fund for Development (FONRID)

Burkina Faso

Represented by Hamidou H. Tamboura

Canadian Institutes of Health Research (CIHR)

Canada

Represented by Charu Kaushic

Secretariat of Government of Science, Technology and Productive Innovation

Argentina

Represented by Diego Galeano

Butantan Institute

Brazil

Represented by Alexander Precioso

Fund for Science, Technology and Innovation (FONSTI)

Cote d’Ivoire

Represented by Annette Ouattara

African Academy of Sciences (AAS)

Kenya

Represented by Thomas Kariuki

Research Council of Norway (RCN)

Norway

Represented by Karine Kålsås

ANRS | Emerging Infectious Diseases

France

Represented by Yazdan Yazdanpanah

National Institute of Health, Department of Medical Sciences

Thailand

Represented by Aree Thattiyaphong

Wellcome Trust

United Kingdom

Represented by Jeremy Farrar

World Health Organization (WHO)

Observer

Represented by Ana-Maria Henao-Restrepo

European Research Infrastructure on Highly Pathogenic Agents (ERINHA)

Observer

Represented by Jonathan Ewbank

Department of Health and Human Services

USA

Represented by Chris Hassell

Ministry of Health

Italy

Represented by Gaetano Guglielmi

Foreign, Commonwealth & Development Office (FCDO)

United Kingdom

Represented by Jo Mulligan

National Health & Medical Research Council (NHMRC)

Australia

Represented by Anne Kelso

Global Outbreak Alert and Response Network (GOARN)

Observer

Represented by Gail Carson

Gavi, the Vaccine Alliance

Observer

Represented by Marta Tufet-Bayona

Fiocruz Institute

Brazil

Represented by Marco Krieger

European & Developing Countries Clinical Trials Partnership (EDCTP)

Observer

Represented by Pauline Beattie

ESSENCE on Health Research Initiative Secretariat (WHO/TDR)

Observer

Represented by Garry Aslanyan

German Federal Ministry of Education and Research (BMBF) / DLR-PT

Germany

Represented by
Dr. Christina Müller

France

USA

Japan

Spain

Mexico

India

Canada

United Kingdom

United Kingdom

Brazil

Egypt

South Africa

Rwanda

Korea

Netherlands

Switzerland

Observer

Burkina Faso

Canada

Argentina

Brazil

Cote d’Ivoire

Kenya

Norway

France

Thailand

United Kingdom

Observer

Observer

USA

Italy

United Kingdom

Australia

Observer

Observer

Brazil

Observer

Observer

Germany

Latest News & Events

Medical and social scientists as strategic advisors: the case of GloPID-R in 2021

Save the date: GloPID-R Africa Hub Launch

Launch of a new tool for funders: Living Roadmap will support stronger coordination of clinical trial responses to epidemics and pandemics

Congratulations to the COVID CIRCLE team for its contributions to improved outbreak preparedness

Resources

Vaccine manufacturability focused on speed

Recommendations & considerations for GloPID-R

GloPID-R Co-Chairs Recommendations following the 2021 GloPID-R Scientific Advisory Group report

COVID-19 Research Recommendations & Considerations for GloPID-R 2021-2023